You will receive alerts when there are new announcements on Paradigm Biopharmaceuticals Ltd
Only registered members can use this feature.
Paradigm Biopharmaceuticals Ltd (ASX:PAR) is listed on the Australian Securities Exchange.
The biotech gained up to 5% by lunch on confirming FY20 milestones, including an early-2020 filing with the US FDA for an OA drug.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.